NL Notes: Nationals, Scherzer, Gallen
Fans of the Nationals received positive injury news today, as their Triple-A affiliate in Rochester announced that left fielder Corey Dickerson is set to begin a rehab assignment. Dickerson signed in Washington on a one-year deal this past offseason, but appeared in just two games for the club prior to the club placing Dickerson on the 10-day injured list with a calf strain. Dickerson, who will celebrate his 34th birthday later this month, is in his eleventh season as a major league player, with a career 112 wRC+.
That solid production would be a boon to a Nationals club that has mostly used 28-year-old outfielder Alex Call in left field while Dickerson has been on the shelf. Call has struggled so far in 143 trips to the plate for the Nationals this season, with a .230/.329/.336 slash line (86 wRC+) so far this season. That being said, Dickerson is not without flaws himself: his wRC+ has declined to a mark of just 97 since the beginning of the 2020 season, and he has hampered by a significant platoon split that has seen him post just a .693 OPS against left-handed pitchers throughout his career.
Fortunately for the Nationals, however, they have a seemingly perfect platoon partner for Dickerson in the form of Stone Garrett, a 27-year-old slugger who has slashed .344/.368/.594 against left-handers in 72 career plate appearances in the majors. Platooning Dickerson with Garrett upon his return to the lineup could help the Nationals solve their offensive woes in left field, where the club’s 85 wRC+ ranks seventh worst in the majors.
Dickerson may not be the only reinforcements on the horizon from the injured list, however. MLB.com’s injury tracker notes that right-hander Chad Kuhl, who signed with the Nationals on a minor league deal during the offseason, threw a simulated game of over 60 pitches earlier this week. Kuhl, who has been on the IL with sprained toe since the beginning of the month, could threaten the spot of right-hander Jake Irvin in the rotation going forward. While Irvin is expected to make his next start, the Nationals figure to reevaluate their rotation after that, with Jesse Dougherty of the Washington Post noting that Kuhl’s return could give the Nationals the opportunity to manage the 26-year-old Irvin’s innings going forward.
More from around the National League…
- Jon Heyman of the New York Post suggests that the Mets, while not concerned about the neck issue that caused veteran right-hander Max Scherzer to be scratched from his start earlier in the week, are worried that the 38-year-old’s ailment near the scapula, which caused the club to push back one of his starts in mid-April, could be an issue that Scherzer will need to manage all year. It’s been a difficult start to the 2023 campaign for Scherzer, who has posted a 5.56 ERA in 22 2/3 innings amid multiple injury concerns and a 10-game suspension for violating the league’s policy on foreign substances.
- As noted by Bob Nightengale of USA Today, budding ace Zac Gallen has expressed interest in staying with the Diamondbacks long term, though he noted a preference for avoiding in-season extension negotiations. Gallen, 27, has emerged as one of the game’s best pitchers in recent years, including a breakout campaign last season that saw him post a 2.54 ERA in 184 innings en route to a top 5 finish in NL Cy Young award voting. Fortunately for Arizona, they have plenty of time to discuss a long term deal with their young ace, who is set to hit free agency after the 2025 campaign.
Mets Notes: Scherzer, Peterson, Yacabonis, Carrasco
The Mets announced that today’s scheduled starter, Max Scherzer, was scratched due to neck spasms. Left-hander David Peterson was recalled to start tonight instead. Right-hander Jimmy Yacabonis was placed on the 15-day injured list with a left quad strain, which opened a roster spot for Peterson and allowed the lefty to return less than 15 days after being optioned.
The issue with Scherzer appears to be minor, as he was not placed on the injured list, but it is at least somewhat concerning that he’s not at full health. The 38-year-old hasn’t quite seemed himself so far this season, seemingly unable to get into a good groove. He allowed eight earned runs in his first two outings but came back with five scoreless frames in his third. It was in his fourth start that he was ejected for excessive stickiness on his hands, which also led to a 10-game suspension. He showed a bit of rust after serving that sentence, allowing six earned runs against the Tigers last week.
All told, he has an ERA of 5.56 thus far, a significant difference from last year’s 2.29 mark. The severity of this neck issue will likely become more clear in the coming days but it appears to be yet another speed bump for a rotation that has seen many. Justin Verlander started the year on the injured list due to a teres major strain and just returned last week while José Quintana has been there all year due to rib surgery and isn’t expected to return until July. Carlos Carrasco began the year healthy but landed on the IL after just three starts due to a bone spur in his elbow. All of those hurdles are part of the reason the club has limped out to a 17-18 start and is seven games back of Atlanta in the NL East.
It remains to be seen whether Scherzer will just need a few days of extra rest or a significant stretch of time off. Peterson will likely be quickly optioned in the former scenario but could also stick around in the latter, joining Verlander, Kodai Senga, Tylor Megill and Joey Lucchesi in the improvised rotation. Scherzer seems to be on the optimistic side of things, telling Tim Healey of Newsday that he’s expecting to miss just a couple of days and take the ball against the Nationals this weekend.
In a bit of good news, Carrasco seems to be working his way back as well. The Double-A Binghamton Rumble Ponies announced that the veteran will be making a rehab start for them tonight as he tries to get back to the major league team. He was initially planned to start his rehab on the weekend but those plans were pushed back when he fell ill. It seems he’s recovered and the train is back on the tracks. He had a 3.97 ERA for the Mets last year but struggled to an 8.56 mark this year before the bone spur put him on the shelf.
If the Mets get a bit of luck, both Scherzer and Carrasco will be healthy and pitching well soon, which will likely nudge out Peterson and then one of Lucchesi or Megill. The former has a 4.43 ERA through four starts while the latter is at 4.33 in seven outings. Peterson hasn’t been able to fare well in his time this year, currently sporting a 7.34 ERA in his six starts.
Max Scherzer Given 10-Game Suspension; Will Not Appeal
7:53pm: In a surprising twist, Scherzer informed reporters this evening he’s elected not to appeal after all (video provided by SNY). The right-hander said he’d initially believed an appeal would be heard by a neutral arbitrator but later was informed it would go in front of an MLB official. (Ken Rosenthal of the Athletic specifies that special assistant to the commissioner John McHale would have heard the appeal.) As a result, Scherzer conceded he wouldn’t win and has elected not to pursue it.
He’ll begin serving his ban tonight and is ineligible to return until May 1. Because Scherzer was suspended for an on-field rules violation, the Mets are not permitted to replace him on the active roster. They’ll roll with 25 players for the remainder of the month.
6:56pm: Major League Baseball announced Thursday evening that Mets star Max Scherzer has been suspended for ten games for “violating the prohibitions on foreign substances.” He was also fined an undisclosed amount, which Jon Heyman of the New York Post reports at $10K (Twitter link).
Foreign substance ejections come with an automatic ten-game suspension, so this has seemed likely since Scherzer was thrown out of yesterday’s start against the Dodgers. Scherzer stated after yesterday’s game that he’d appeal any suspension. Heyman tweets this evening that he plans to do so. Scherzer has been adamant he was only using legally-permissible rosin, swearing on the life of his children in the process. Umpires Phil Cuzzi and Dan Bellino, however, explained after the game that Scherzer’s hand was stickier than any other they had inspected previously.
Bellino opined that Scherzer had used “something likely more than rosin” based on its stickiness. MLB’s announcement reflected a similar sentiment. “Based on the umpires’ training to detect rosin on a pitcher’s hands, they concluded that the level of stickiness during the fourth inning check was so extreme that it was inconsistent with the use of rosin and/or sweat alone,” the league wrote. MLB’s press release says umpires “appropriately ejected Mr. Scherzer from the game” at that point.
While the league apparently believes Scherzer applied an illicit substance other than rosin, its press release also points to another potential justification for the ejection/suspension. MLB points out that it sent a memo to clubs during Spring Training reminding that “when used excessively or otherwise misapplied (i.e., to gloves or other parts of the uniform), rosin may be determined by the umpires to be a prohibited foreign substance, the use of which may subject a player to ejection and discipline.” Whether because of the umpiring crew’s determination Scherzer had used a non-rosin sticky substance or the possibility the three-time Cy Young winner applied too much of the otherwise permissible rosin, the league imposed discipline.
It was reported back in June 2021 the league was planning to crack down on the use of “sticky stuff” that pitchers use to improve their grip on the baseball but also to increase spin rates. Two players were suspended not too long after that, with Héctor Santiago of the Mariners getting hit later that same month, followed by Caleb Smith of the Diamondbacks in August. No suspensions were handed out last year, but it was reported in February the league was planning to further crack down this year.
Scherzer declined comment when speaking with Mets’ reporters this evening. He said only that his camp is “working on it” in reference to fighting the ban (relayed by Anthony DiComo of MLB.com). There’s sure to be more clarity on the appeals process over the next few days.
If Scherzer indeed has to sit out for a week and a half, it’ll deal another hit to a rotation already down Justin Verlander, José Quintana and Carlos Carrasco to injury. That has pushed David Peterson and Tylor Megill into the starting five alongside Kodai Senga and previously necessitated a spot start from José Butto.
Skipper Buck Showalter told reporters tonight that left-hander Joey Lucchesi will be recalled from Triple-A Syracuse to start tomorrow’s game against the Giants (via Mike Puma of the New York Post). It’ll represent Lucceshi’s first MLB action in nearly two years. He lost all of last season to Tommy John surgery.
2023-24 Player Option/Opt-Out Update: April Edition
Not long ago, any given year in Major League Baseball might have seen a handful of players have player options to decide upon at the end of a season. Opt-out clauses have slowly worked their way into normalcy among contract negotiations, however, and what was once a perk typically reserved for star players has become more commonly used as a means of either sealing a deal with mid-range free agents or in many instances, gaming the luxury tax. Player options are considered guaranteed money, after all, so it’s become common for clubs on the precipice of luxury penalization to negotiate complex player options that tamp down a contract’s average annual value even though they’re unlikely to ever be exercised.
For the purposes of this look around the league, there’s little sense in separating opt-outs from player options. The two are effectively the same, though “opt-out” typically refers to an out clause where there are multiple years remaining on the contract and “player option” generally refers to an individual decision on the forthcoming season. Both are considered guaranteed money for luxury purposes, and both ultimately come down to the player’s preference, risk tolerance, etc.
At their core, opt-out provisions aren’t particularly different from the much longer-accepted club options that teams have negotiated for years. Teams guarantee a certain number of dollars over a certain number of years, and if the player continues performing at a high enough level, they’ll exercise a club option that’s typically locked in at a below-market price. If not, the player will be bought out and sent back to free agency. Player options and opt-outs are merely the inverse; the player/agent negotiate a certain length and annual value but reserve the right to opt back into the market if the player continues to perform at a high level. It’s two sides of the same coin.
There are more players with the opportunity to opt out of their contract this offseason, by way of a one-year player option or a multi-year opt-out, than ever before. As such, we’ll be keeping tabs on these situations throughout the season. Short of a major injury, performance this early in the season isn’t likely to have a major impact on a player’s likelihood of opting out or forgoing that right, but it’s worth listing out which players will have the opportunity, what their contracts look like, and at least taking an early glance at how they’re performing.
Note: All stats through play on Tuesday.
Position Players
- Tucker Barnhart, C, Cubs ($3.25MM player option): Barnhart’s deal was announced as a two-year, $6.5MM contract, though he also obtained the right to opt out after 2023, effectively rendering 2024 a player option. He’s 5-for-16 with a walk and four strikeouts through just 17 plate appearances as the backup to Yan Gomes. Barnhart got this guarantee on the heels of a dismal .221/.287/.267 showing with the Tigers in 2022, so with even a decent season he’ll have reason to opt out and try his luck again amid a thin group of free-agent catchers.
- Josh Bell, 1B/DH, Guardians ($16.5MM player option): Bell limped to the finish line with the Padres after being traded over from the Nationals alongside Juan Soto in last summer’s blockbuster, and he hasn’t yet found his footing in 76 plate appearances with the Guardians. It’s a small sample, but Bell’s .203/.316/.344 slash looks quite similar to the .192/.316/.271 he mustered with San Diego in 2022. Bell hit 37 homers in 2019 and 27 in 2021, but he hits the ball on the ground far too often for someone with his power and lack of speed. Only one qualified hitter in MLB (Masataka Yoshida) has a higher ground-ball rate than Bell’s staggering 66.7% mark.
- Trey Mancini, 1B/OF, Cubs ($7MM player option, if he reaches 350 plate appearances): Like Bell, Mancini saw his offensive production crater following a deadline trade (to the Astros) last summer and has not yet recovered in a new setting. Through 60 plate appearances, he’s hitting just .196/.220/.250. While his contract is a two-year, $14MM deal, Mancini can opt out if he reaches 350 plate appearances (i.e., the second year becomes a player option). He isn’t hitting yet, but Mancini is playing regularly and appears to be trending toward earning that right.
- Javier Baez, SS, Tigers (can opt out of remaining four years, $98MM): After turning in a tepid .238/.278/.393 batting line in 590 plate appearances during his first season as a Tiger, Baez would need quite the season to walk away from this kind of cash. So far, he’s hitting .193/.254/.246 in 64 trips to the plate, however. When Baez gets hot, he can go on hot streaks for the ages, but he certainly doesn’t look like he’ll be opting out at season’s end.
- Justin Turner, 3B/DH, Red Sox ($13.4MM player option): Turner hasn’t found his power yet in Boston, but he’s out to a .277/.385/.385 start with nearly as many walks as strikeouts. His $13.4MM player option comes with a hefty $6.7MM buyout. He’ll turn 39 in November, but as long as he hits reasonably well, he should have more earning power than that $6.7MM net decision.
- Jorge Soler, OF/DH, Marlins ($9MM player option): Soler’s three-year, $36MM deal in Miami pays him $12MM in 2022, $15MM in 2023 and $9MM in 2024, but he had the right to opt out after each season of the deal. He hit just .207/.295/.400 with 13 homers in 306 plate appearances last year, so there was no way he was taking the first opt-out. He’s already clubbed five dingers in 62 plate appearances in 2023. His .263/.323/.649 slash translates to a 155 wRC+, and his exit velocity and hard-hit rate are through the roof, so his .256 average on balls in play should at least hold steady. Soler is an extremely streaky hitter, so time will tell how much of this early heater he can sustain, but there’s plenty to like about his start, including a reduced strikeout rate.
- Michael Conforto, OF, Giants ($18MM player option, if he reaches 350 plate appearances): As with Mancini, Conforto is on a two-year deal but gains the right to opt out after one year if he reaches 350 plate appearances. You can call it an opt-out or a player option, but it’s the same mechanism; if Conforto is healthy, he’ll likely get the right to opt out. So far, he’s hitting .220/.373/.439 with a trio of homers in 51 trips to the plate. Conforto has walked nine times in those 51 plate appearances (17.6%), and his chase rate is actually down, so he still has good knowledge of the zone. However, a year-long layoff due to shoulder surgery is perhaps making itself known with a 74.5% contact rate on pitches in the strike zone, as that’s nearly 10 percentage points below his career mark of 84%. Unsurprisingly, Conforto’s 31.4% strikeout rate is a career worst. Some rust was inevitable, though, and the plate discipline and hard contact when he has made contact (94.4 mph exit velo, 52.5% hard-hit rate) are encouraging.
- Matt Carpenter, 1B/DH, Padres ($5.5MM player option): Carpenter’s stunning return with the Yankees last year was one of the best stories of the summer, but he’s out to a sluggish .152/.317/.273 start with the Padres. He’s chasing off the plate at a 30.3% clip after doing so at a 20.7% rate last summer, and his contact rate on swings off the plate has plummeted from 62.5% to 36.4%. It’s a small sample and there’s time to turn things around, of course, but he’s had a tough start.
Pitchers
- Andrew Heaney, LHP, Dodgers ($13MM player option): Heaney’s first Rangers start was one to forget (seven earned runs), but his second start was dominant, as he tied an AL record by fanning nine consecutive hitters. If Heaney tops 150 innings and doesn’t finish the year with an injury that’d likely keep him out for the first 60-plus innings of the 2024 season, the value of that player option jumps to $20MM. He hasn’t reached 150 innings since 2018.
- Seth Lugo, RHP, Padres ($7.5MM player option): Lugo’s return to the rotation has been solid. He’s posted a 2.70 ERA through 16 2/3 frames with strikeout and walk ratios that look similar to his numbers out of the bullpen (24.3% strikeout rate, 7.1% walk rate). It’s anyone’s guess how many innings Lugo will tally after throwing just 228 innings combined from 2019-22, when he was primarily a reliever, but a solid run out of the rotation will position him to turn down that player option in search of a multi-year deal in free agency.
- Sean Manaea, LHP, Giants ($12.5MM player option): The early ERA isn’t much to look at (4.76 in 11 1/3 innings), but the Giants have Manaea averaging 94.7 mph on his four-seamer. That’s a career-high by a wide margin, as he sat 91.7 mph on a now-scrapped sinker in 2021-22 and 91.1 mph on his four-seamer in 2017-20. Any major velocity gain of this nature is worth keeping an eye on.
- Nick Martinez, RHP, Padres (team has two-year, $32MM club option; if declined, Martinez has two-year, $16MM player option): Martinez’s strikeout rate, walk rate, home-run rate and velocity have all gone the wrong direction through his first three starts. It’s just 17 2/3 innings, so it could be rendered a footnote if he rebounds and the Padres pick up their hefty option on the righty. Still, it’s not the start he or the Padres wanted.
- Eduardo Rodriguez, LHP, Tigers (can opt out remaining three years, $49MM): E-Rod hasn’t missed bats anywhere near his Boston levels since signing with the Tigers. The lefty still showed good command both in 2022 and so far in 2023, but his 8.7% swinging-strike rate and 20.4% strikeout rate are well shy of the respective 11.6% and 26% marks he posted in his final four years with the Red Sox. Rodriguez’s velocity in 2023 is back up after a slight dip in 2022, but if he can’t get back to missing bats at his prior levels it’ll be an easy call for him to forego that opt-out provision.
- Max Scherzer, RHP, Mets ($43.333MM player option): Scherzer hasn’t gotten out to his best start, but he posted a 2.29 ERA with gaudy strikeout and walk rates (30.6% and 4.2%) in 145 1/3 frames with the Mets in 2022. He was at the center of controversy after being ejected from today’s start after failing a foreign substance check, though that’s not likely to have any effect on his opt-out decision. Scherzer has already suggested that his opt-out was negotiated in part to ensure that he’d have an opportunity to look elsewhere if the Mets didn’t remain fully committed to winning. That hasn’t been the case under owner Steve Cohen, who’s currently financing the largest payroll and luxury-tax bill in MLB history.
- Ross Stripling, RHP, Giants ($12.5MM player option): Stripling has been ambushed for 10 runs in his first 12 1/3 innings of work and had been set to operate primarily out of the bullpen before the injury to Alex Wood. It’s not a great start considering the weighty $25MM guarantee on his deal, but he has time to turn things around. A stunning six of the 13 fly-balls Stripling has yielded in 2023 have cleared the fence for a home run, and that rate will surely stabilize over a larger sample. Still, if he’s relegated to long-relief duty for too long, it’ll become difficult for him to even consider his opt-out.
- Marcus Stroman, RHP, Cubs ($21MM player option): Stroman took a rather atypical contract structure for a 31-year-old free agent, inking a three-year guarantee at a premium annual value with an opt-out after year two. It’s more common to see pitchers that age push for the longest deal possible, but it might work out in Stroman’s favor. He’ll bank $50MM through the contract’s first two seasons, and after a nice 2022 season (3.50 ERA, 3.74 SIERA in 138 2/3 innings), he’s come roaring out of the gates with a 0.75 ERA and vastly improved 26.9% strikeout rate through his first 24 frames. Stroman’s walk rate is also up, and it’s all a small sample for now anyway, but it’s a promising start all the same. He’ll turn 33 in 2024, and if he continues anywhere near the pace he’s set since 2019 (3.15 ERA in 520 innings), he should have no problem topping that $21MM in free agency. He’ll also be ineligible for a qualifying offer, having already received one earlier in his career.
- Michael Wacha, RHP, Padres (two-year, $32MM club option; if declined, Wacha has $6.5MM player option and $6MM player options in 2025-26): Wacha’s four-year, $26MM deal was effectively just the Padres manipulating the luxury tax by meeting Wacha’s price tag on a multi-year deal but spreading out the term to tamp down the AAV. Wacha’s total guarantee is the type of money one might’ve expected him to land over a two- or perhaps three-year term. By spreading it to four, the Padres could end up avoiding the third luxury-tax bracket. Wacha has a 6.06 ERA through three starts and posted an ERA of 4.76 or worse each season from 2019-21. If he can wind up replicating his strong 2022 results, the Padres might consider picking up their end of the option, but the likelier scenario is that they decline, leaving Wacha with a remaining three years and $19MM, but opt-outs after each season.
- Chad Green, RHP, Blue Jays (three-year, $27MM club option; if declined, Green has $6.25MM player option; if both decline, team has two-year, $21MM option): Green may have the most convoluted contract of the entire free-agent class. That’s reflective both of his considerable talent and the broad range of outcomes as he works back from last May’s Tommy John surgery. We won’t know have an inkling of how this’ll play out until at least the summer, as Green needs to finish off his rehab. If he can return to peak form (1.83 ERA, 40.7% strikeout rate, 6.7% walk rate) for three or so months down the stretch, perhaps the Jays would actually consider the three-year, $27MM option. But that’s premium setup man money, and Green will be coming back from a year-long absence with a major surgery on his recent resume. He’ll have a $6.25MM player option if that three-year team option is declined, and that seems far more plausible. The two-year, $21MM option if both parties decline their first options feels only slightly more viable than the Jays’ original 3/27 decision.
Scherzer, Boras, Umpires Discuss Foreign Substance Ejection
The sticky stuff crackdown returned to the forefront of MLB attention this afternoon. Mets ace Max Scherzer was ejected after three innings in today’s contest against the Dodgers. An agitated Scherzer was thrown out by crew chief Phil Cuzzi after an extended conversation and inspection of his hands (video provided by Fox Sports MLB).
Failed foreign substance checks come with an automatic 10-game suspension. MLB hasn’t officially levied any discipline to this point, though it’s widely expected the eight-time All-Star will be hit with a suspension. Scherzer told reporters after the game he planned to appeal if suspended (via Bob Nightengale of USA Today).
Scherzer proclaimed his innocence, saying umpires had only detected a combination of sweat and permissible rosin (relayed by Steve Gelbs of SNY). “I said I swear on my kids’ life I’m not using anything else. This is sweat and rosin, sweat and rosin. I keep saying it over and over.” Scherzer added that he anticipated a substance check before the fourth inning, saying he’d “have to be an absolute idiot” to apply anything else.
The three-time Cy Young winner said his hand had gotten “clumpy” with rosin during the second inning. That’s apparently not atypical, as Cuzzi told the pitcher to wash his hand. Scherzer was adamant he washed it with alcohol and changed his glove before reapplying rosin headed into the fourth.
Scherzer’s agent Scott Boras predictably came to his defense. In a statement to Joel Sherman of the New York Post (on Twitter), Boras attacked what he perceived as umpire subjectivity. “MLB standards and rules enforcement should mandate and require an objective verifiable standard,” Boras said. “If you want to attack the integrity of the competition, you need clear precise standards (or) else you damage the game and its players. The Cuzzi on field spectrometer is not the answer. MLB needs to employ available scientific methods (not subjective) to create verifiable certainly of its rules.”
Cuzzi and home plate umpire Dan Bellino defended their actions after the game. “This was the stickiest [a hand] has been since I’ve been inspecting hands, which goes back three seasons,” Bellino said (via Mike DiGiovanna of the Los Angeles Times). “It was so sticky that when we touched his hand, our fingers were sticking to his hand.” He went on to call it “far more than we have ever seen before on a pitcher in live action” and noted that umpires are aware of the consequences for pitchers ejected for foreign substances, implying they don’t take lightly the expected suspension in making that decision (transcribed by Mike Puma of the New York Post).
Cuzzi made a similar argument, saying Scherzer’s hand was “far stickier than anything that we felt certainly today and anything this year. And so in that case, we felt as though he had two chances to clean it up and he didn’t” (relayed by Tim Healey of Newsday). Bellino called it “something likely more than rosin” in his judgment (thread via Jesse Rogers of ESPN). “We know what the rosin typically feels like on a pitcher’s hand because everyone is using the same rosin bag,” he added. Rogers notes that while rosin itself is not a banned substance, it can be impermissible if used excessively or misapplied.
Drawing that line presents a judgment call for an umpiring crew. Scherzer’s ejection was the first for a failed substance check since the end of the 2021 campaign. Yankees righty Domingo Germán had a close call during a start against the Twins last week, when umpires twice warned him for using too much rosin (link via Dan Hayes of the Athletic). Germán was allowed to stay in the game after washing the rosin to the umpiring crew’s satisfaction. That displeased Twins manager Rocco Baldelli, who was ejected for arguing against Germán being allowed to continue. Dodgers skipper Dave Roberts said that Los Angeles did not request any of the glove inspections in Scherzer’s case (via Rowan Kavner of Fox Sports).
It’s only the beginning of what figures to be a notable saga if/when MLB levies a suspension. In suspensions for violations of on-field rules, clubs are required to play a man short while the ban is being served. The Mets already have three starters — Justin Verlander, José Quintana and Carlos Carrasco — on the injured list.
NL East Notes: Scherzer, Arcia, Sosa, Suarez, Harper
Max Scherzer was scheduled to start for the Mets on Sunday against the Athletics, but Jose Butto will now take the hill tomorrow and Scherzer will be pushed to Wednesday. Mets manager Buck Showalter told the New York Post’s Mike Puma (Twitter links) and other reporters that Scherzer has some “lingering soreness” in his side, though Scherzer said that scans of the area below his scapula didn’t reveal any structural damage.
Butto was tentatively expected to receive a spot start at some point during the Mets’ road trip, so today’s news seems mostly precautionary in nature, notwithstanding Scherzer’s injury history. There might also be a bit of gamesmanship at play, since rather than face the struggling A’s, Scherzer is now lined up to face the Dodgers on Wednesday in a game with more implications on the NL playoff race.
More from around the NL East…
- Orlando Arcia‘s microfracture in his left wrist will be re-evaluated in 10-14 days, the Braves told reporters (including MLB.com’s Mark Bowman). Arcia was placed on the 10-day injured list yesterday and will obviously miss more than the minimum number of days, but a more thorough timeline won’t be known until Arcia is next examined by doctors. Arcia entered the season with the twin momentum of a new contract extension and a role as Atlanta’s starting shortstop, and he was hitting a hefty .333/.400/.511 over 50 plate appearances prior to his injury.
- Edmundo Sosa left today’s game due to discomfort in his lower back, according to the Phillies. Since Philadelphia was trailing 8-0 to the Reds at the time of Sosa’s departure in the bottom of the sixth, it could be that Sosa was just being given a rest from the last few innings of what ended up as a 13-0 rout. If Sosa did have to miss any time, it would further stretch the depth of a Phillies infield that is already missing Rhys Hoskins and Darick Hall, as Sosa was seeing more action at third base while Alec Bohm had moved to first base.
- In other Phillies injury news, Ranger Suarez will throw to live hitters during a simulated game on Tuesday, Scott Lauper of the Philadelphia Inquirer writes. Suarez has yet to pitch this season due to forearm inflammation, and he’ll be facing at least prominent batter during that sim game in the form of Bryce Harper, who will face live pitching for the first time in his rehab from Tommy John surgery. Initially given a return timeline of around the All-Star break, there continue to be hints that Harper might be back sooner, including the fact that both Harper and manager Rob Thomson don’t feel Harper will need a minor league rehab assignment before re-entering Philadelphia’s lineup. Given the Trajekt Arc video projection system installed at Citizens Bank Park, Harper can somewhat replicate facing MLB-level pitching during his batting cage work, rather than face live minor league pitching during a rehab assignment.
NL East Notes: Scherzer, Soroka, Song, Phillies
Max Scherzer‘s three-year deal with the Mets is now one-third of the way complete and will afford him the ability to opt out at the end of the upcoming season. Andy Martino of SNY asked Scherzer about that forthcoming choice and the pitcher was fairly noncommittal about it, complimenting the direction of the organization but also acknowledging the business aspect of things.
“You have to understand the context of why I negotiated that in, and the context of where we’re at now,” Scherzer said, before elaborating that he didn’t know what to expect from the club if Jacob deGrom triggered his own opt-out at the end of 2022. “It was, if Jake opts out, you didn’t know what was going to happen. You didn’t know where the Mets would be as an organization. A big draw for me to come to New York was to get the chance to pitch with him, and here he has an opt out in year one. If he did take it and go somewhere else, what is the organization going to do?” After a chuckle, he said, “I got an answer.” Of course, he now knows that owner Steve Cohen was willing to spend lavishly on free agents, ramping the club’s payroll to the top of the league in order to field a competitive team for 2023.
That response from Scherzer stands in contrast to that of deGrom, who was quite clear at this time last year that his plan was to trigger his opt-out. It’s been a similar story lately with Padres third baseman Manny Machado, who’s openly declared his intention to opt out of his deal this fall. The fact that Scherzer isn’t quite so emphatic is perhaps somewhat hopeful for Mets fans, but it could also come down to a business decision, something Scherzer acknowledged as well. “If it becomes a business situation, we will cross that bridge at a different time,” he added. “At the end of the year, that will get taken care of … I’m not thinking about it. Obviously, you go through six months of the baseball season, anything can change. So it’s not even worth it to comment on whether I’m going to use it or not.”
If Scherzer has another typical ace season, he would be facing an interesting decision from a business perspective. He will turn 39 years old in July and be deciding whether or not to leave $43.33MM on the table and become a free agent again. That’s a lot of money to turn down for a player that age, but his now-teammate Justin Verlander secured himself a two-year, $86.66MM guarantee going into his age-40 season, the same average annual value. With that in mind, Scherzer might actually leave more money on the table by not triggering his opt-out. If he were to decide to depart, the Mets would be losing two members of its current rotation, as Carlos Carrasco is in the final year of his contract.
Some other notes from around the National League East…
- Braves right-hander Michael Soroka is dealing with a sore hamstring that will prevent him from taking the mound for about a week and from appearing in spring games for a few weeks. “It’s a kick in the groin,” Soroka said to David O’Brien of The Athletic about the setback. “Pretty frustrating, especially given the early offseason for me, just to be able to get ready for this spring training. Then coming down with that was not fun. But that’s how it goes, and we’ll be moving forward here pretty shortly.” Soroka has been significantly impeded by injuries in recent years, with his 2020 cut short after three starts due to a torn right Achilles. The recovery has been quite arduous, involving three surgeries as he missed the past two seasons entirely. This latest issue doesn’t seem to be huge, but it’s understandably frustrating that there’s yet another hurdle to clear. In 2019, Soroka made 29 starts with a 2.68 ERA over 174 2/3 innings. He figured to compete with Ian Anderson for the club’s fifth starter spot this year but he might have to play a bit of catch-up whenever he’s healthy. He does still have an option year remaining, should he need more time in the minors to get stretched out after this delay.
- The Phillies informed reporters, including Alex Coffey of the Philadelphia Inquirer, that right-hander Noah Song has been discharged from the Navy and is expected to be in camp tomorrow. (EDIT: The club later clarified Song has not been discharged, but was transferred from active duty to selective reserves, which allows him to play baseball. Twitter link from Matt Gelb of The Athletic.) Song, 26 in May, was drafted by the Red Sox in 2019 but his baseball career was put on hold when the Department of Defense ordered the United States Naval Academy graduate to report to flight school. He was left unprotected in the most recent Rule 5 draft and was selected by the Phillies, whose president of baseball operations Dave Dombrowski was with the Red Sox at the time Song was first drafted. Some considered him a first-round talent back then, though he lingered until the fourth round due to concerns around that military commitment. This will now be an interesting and unusual experiment, as Song still hasn’t pitched professionally since a stint at Low-A in 2019. He was quite good at that time, posting a 1.06 ERA over seven starts but will now be jumping straight to the majors. As a Rule 5 draftee, he will have to stick on the active roster all season or put on waivers and then offered back to the Sox if he clears. The Phils could also pursue trades, though any acquiring team would face the same roster restrictions as the Phils themselves currently face. Song is currently on the military list and isn’t taking up a spot on the 40-man roster, with Gelb relaying that he will have to be added by Opening Day.
- Sticking with the Phillies, they will be navigating an open designated hitter slot until Bryce Harper returns from Tommy John surgery. The most recent estimate on that timeline has Harper returning around the All-Star break in July, giving the club a span of over three months to navigate. It seems the plan is to not have any single player entrenched in the spot and spread those opportunities around. “At this point, I think it’s a rotation,” manager Rob Thomson tells Gelb. “Getting people off their feet. Giving them a half day, so to speak.” In order to shuffle different players through there, positional versatility will be key. It was previously reported that infielder Edmundo Sosa will be getting some work in center field in order to increase his chances of getting playing time. Thomson also highlighted Josh Harrison as someone who could also see extensive action, given his ability to play all multiple positions. He’s played every position except catcher in his career, though he’s spent more time at second and third base than anywhere else. Thomson also mentioned the bat of Darick Hall, who hit nine home runs in his first 42 major league games last year. He’s been almost exclusively a first baseman in his professional career but the club is considering getting him some outfield work to help his bat into the lineup. “If he swings the bat the way he did last year,” Thomson said, “it’s going to be tough to keep him off the club.”
Mets Reinstate Max Scherzer, Tylor Megill
The Mets announced a series of roster moves prior to today’s game, reinstating right-hander Max Scherzer from the 15-day injured list and fellow righty Tylor Megill from the 60-day IL. The club already had a vacancy on their 40-man roster for Megill but needed to open two spots on the active roster, doing so by optioning right-hander Stephen Nogosek and left-hander Alex Claudio.
Scherzer returns after just a minimum stay on the 15-day IL, which is surely a huge relief for everyone in the Mets’ world. Scherzer had missed about six weeks earlier in the season due to a left oblique strain and seemed to injure himself in the same area a couple of weeks ago. Scherzer and the club were hopeful that they had caught the issue early, referring to it as mere “fatigue” in the muscle. They had expressed optimism that the righty could return after a short breather on the IL, which has indeed come to pass.
When healthy enough to take the mound, the 38-year-old has been everything the Mets could have hoped for when they signed him in the offseason. Through 20 starts, he has a 2.26 ERA, 30.6% strikeout rate, 4.6% walk rate and 29.3% ground ball rate. Despite missing extensive time, he’s accrued 4.1 wins above replacement in the eyes of FanGraphs, ranking him 12th in the majors. He’ll now return to the rotation alongside Jacob deGrom, Carlos Carrasco, Taijuan Walker and Chris Bassitt, one of the rare moments this year when the club’s top five starters have all been healthy at the same time. That could potentially be a difference maker over the final two weeks of the schedule, with the Mets clinging to the top spot in the NL East but just one game ahead of Atlanta.
Earlier in the year, when the rotation was not fully healthy, the Mets turned to Megill to help fill in. He performed admirably at first, not allowing a run in his first two starts and holding onto a 1.93 ERA through the end of April. Unfortunately, he was hit hard over the next few weeks and then was placed on the IL in mid-June due to a right shoulder strain, only returning today. His ERA on the season jumped up to 5.01 during that rough stretch, though it’s fair to wonder if the shoulder issues were contributing to that. He has been rehabbing in the minors over the past three weeks but in single-inning relief appearances. That figures to be his role the rest of the way, though it has been previously reported that the Mets plan on returning him to a starting role next season. There’s a lot of uncertainty about next year’s rotation, since deGrom, Walker, Bassitt and Carrasco all have options or opt-outs, leaving Scherzer as the only one of the current group that’s guaranteed to return.
Injury Notes: Scherzer, Lowe, Cavalli, Ashby
The Mets have been without Max Scherzer for the past ten days, as the three-time Cy Young winner has battled some fatigue in his left oblique. That was a bit of a concern given that a strain in the muscle cost him around two months earlier this season, but Scherzer looks as if he’s on track to be reinstated when first eligible next Monday. He made a rehab start with Triple-A Syracuse tonight, tossing 59 pitches over 3 2/3 innings. After the game, Scherzer told reporters he feels “excellent” and would be ready to rejoin the big league rotation at the beginning of next week (via Anthony DiComo of MLB.com).
Scherzer’s prompt return is obviously a boon for a Mets team battling for a division title down the stretch. At 89-55, New York holds a half-game advantage over the Braves in the NL East. They’re a postseason lock, but securing the division is likely to come with a first-round bye as a top-two seed in the National League. New York is five games clear of the third-seeded Cardinals, who lead the NL Central, putting the East winner in good position to join the Dodgers in earning an immediate trip to the NL Division Series.
Some other injury updates around the game:
- The Rays just placed Brandon Lowe on the 10-day injured list yesterday, the second baseman’s third such stint of the 2022 season. Manager Kevin Cash told reporters (including Marc Topkin of the Tampa Bay Times) that an MRI revealed some inflammation in Lowe’s back. He’s headed for further evaluation to determine treatment possibilities, but Cash indicated the club is still hopeful he’ll return to the diamond this season. The Rays look set to mix-and-match at second base while Lowe’s out, giving the last three starts at the position to Taylor Walls, Jonathan Aranda and Isaac Paredes respectively. Walls is the best defender of the group, but he’s not hit well this year. Paredes has only a .293 on-base percentage but has connected on 18 home runs in 92 games. Aranda has only 15 big league games under his belt, but he’s raked at a .318/.394/.521 clip through 465 plate appearances with Triple-A Durham.
- Nationals right-hander Cade Cavalli has been out for the past two weeks after being diagnosed with inflammation in his throwing shoulder. That seems likely to end his season, as manager Dave Martinez told reporters (including Bobby Blanco of MASNsports.com) that Cavalli is unlikely to make it back to game action this year. With three weeks remaining and the Nationals virtual locks for last place, there’s no reason for the club to take any chances with the prized young hurler. Martinez indicated that Cavalli has been cleared to start throwing after a brief shutdown period and the team feels he’ll be able to work from a mound before the season is out, but it seems that’ll be in a bullpen session rather than in-game work. Cavalli, generally regarded as the top pitching prospect in the organization, made his first MLB appearance on August 26. He’s likely to compete for a job in the season-opening rotation as Washington continues their rebuild next year.
- Aaron Ashby returned to a mound for the first time since landing on the injured list three weeks ago, tossing an 18-pitch bullpen session this afternoon (reported by Adam McCalvy of MLB.com). He’s scheduled for another bullpen session over the weekend. The Brewers remain hopeful the southpaw will be able to make it back this season, although he’d work in shorter stints due to the abbreviated ramp-up period. Ashby has started 17 of his 23 appearances this year, but he came out of the bullpen for nine of his 13 outings in 2021. He’s thrived as a reliever in his MLB career, posting a 3.63 ERA with a 36.2% strikeout rate through 34 2/3 innings in that capacity. Ashby has been a bit more erratic when trying to navigate a lineup multiple times as a starter, although he’s still flashed the swing-and-miss and ground-ball combination that made him such a promising pitching prospect. Milwaukee sits two games back of the Padres for the National League’s final Wild Card spot, so they’d surely welcome any contributions they can get from the 24-year-old for the stretch run.
Mets Designate Adonis Medina For Assignment
The Mets designated right-hander Adonis Medina for assignment, and also made Max Scherzer‘s 15-day IL placement official. In corresponding moves, New York selected the contract of left-hander Alex Claudio and called up right-hander Yoan Lopez from Triple-A. Lopez will be the 29th man for today’s doubleheader against the Pirates.
Medina has been up and down from Triple-A multiple times this season, and all of the shuttling may have had an adverse effect on his performance. The righty has a 6.08 ERA over 23 2/3 innings with the Mets and a more palatable 3.71 ERA in 26 2/3 frames for Triple-A Syracuse, though Medina’s minor league walk rate is a troubling 12.1%.
This is the third time that Medina has been designated for assignment within the last year, with the first of those DFA stints keeping Medina in transactional limbo throughout the entirety of the offseason lockout. The Pirates claimed Medina off waivers from the Phillies once the lockout was over, and a subsequent DFA from Pittsburgh resulted in Medina being traded to the Mets just prior to Opening Day.
Medina received some top-100 prospect attention as recently as 2019, but he has yet to make a big impact in the majors, pitching only 11 2/3 innings with the Phillies prior to this season. Generally a below-average strikeout pitcher, Medina has posted grounder rates around the 50% mark during his career, usually relying more on soft contact and keeping the ball in play rather than missed bats. Medina has worked as a starter for much of his career but he primarily been a reliever this season in Syracuse, and his 14 Mets appearances were all out of the bullpen.
Claudio inked a minor league deal with the Mets during the offseason, and the southpaw is now on the verge of making it a ninth consecutive season with some MLB action. Speaking of low-strikeout grounder specialists, Claudio has a 17% strikeout rate and 59.8% groundball rate over his 344 1/3 career innings in the majors. Claudio was a generally reliable bullpen arm throughout his time with the Rangers and Brewers from 2014-20, posting a 3.44 ERA and eating plenty of innings — his 83 appearances led the big leagues in 2019.
The Brewers opted to non-tender Claudio following the 2020 season, in part due to his lack of strikeouts or high velocity, as well as the idea that Claudio (who has pretty big career splits) would be hampered by the three-batter rule. Signing with the Angels in the 2020-21 offseason, the southpaw had only a 5.51 ERA over 32 2/3 innings with Anaheim in 2021, and also pitched in the Red Sox farm system after the Angels cut him loose midway through the campaign.
The Mets’ lack of left-handed relief depth has been an ongoing story of their season, with Joely Rodriguez being the only southpaw regular within the bullpen mix. Such left-handed pitchers as Chasen Shreve, Nate Fisher, Rob Zastryzny, Sam Clay, and Thomas Szapucki have all gotten some looks, and Claudio will become the latest southpaw to get a shot at catching on as extra depth.